T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UCB
1876
United Community Banks
UCB
$4.42B
| $909K | ﹤0.01% |
31,822
+173
| +0.5% | +$4.72K |
|
1877
NN Inc
NNBR
$300M
| $908K | ﹤0.01% |
93,030
+100
| +0.1% | +$868 |
|
1878
Coeur Mining
CDE
$18.7B
| $906K | ﹤0.01% |
208,833
+172,164
| +470% | +$606K |
|
1879
Nabors Industries
NBR
$1.34B
| $898K | ﹤0.01% |
6,194
+1,310
| +27% | +$209K |
|
1880
First Busey Corp
BUSE
$2.59B
| $897K | ﹤0.01% |
33,948
+173
| +0.5% | +$4.42K |
|
|
PINC
1881
DELISTED
Premier
PINC
| $895K | ﹤0.01% |
22,872
+47
| +0.2% | +$1.7K |
|
|
GTY
1882
Getty Realty Corp
GTY
$2.08B
| $894K | ﹤0.01% |
29,054
+137
| +0.5% | +$4.37K |
|
1883
Digimarc Corp
DMRC
$156M
| $892K | ﹤0.01% |
20,091
-10,779
| -35% | -$491K |
|
|
WAGE
1884
DELISTED
WageWorks, Inc.
WAGE
| $888K | ﹤0.01% |
17,476
-1,300
| -7% | -$61.5K |
|
1885
Federal Agricultural Mortgage
AGM
$2.53B
| $885K | ﹤0.01% |
12,181
+10
| +0.1% | +$736 |
|
1886
Myriad Genetics
MYGN
$301M
| $885K | ﹤0.01% |
31,842
+173
| +0.5% | +$4.89K |
|
1887
Walker & Dunlop
WD
$1.43B
| $884K | ﹤0.01% |
16,615
+61
| +0.4% | +$3.23K |
|
|
TYPE
1888
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $884K | ﹤0.01% |
52,483
+123
| +0.2% | +$2.19K |
|
1889
Heron Therapeutics
HRTX
$63.6M
| $882K | ﹤0.01% |
47,453
+322
| +0.7% | +$6.43K |
|
1890
SPX Corp
SPXC
$10.9B
| $879K | ﹤0.01% |
26,620
+113
| +0.4% | +$3.77K |
|
1891
Artivion
AORT
$1.38B
| $876K | ﹤0.01% |
29,276
+3,046
| +12% | +$90.4K |
|
1892
Hecla Mining
HL
$11.8B
| $876K | ﹤0.01% |
486,679
+124,956
| +35% | +$229K |
|
1893
Element Solutions
ESI
$9.46B
| $869K | ﹤0.01% |
84,073
+745
| +0.9% | +$7.84K |
|
|
MGLN
1894
DELISTED
Magellan Health Services, Inc.
MGLN
| $864K | ﹤0.01% |
11,642
+49
| +0.4% | +$3.29K |
|
1895
SiriusPoint
SPNT
$2.68B
| $861K | ﹤0.01% |
83,388
-2,095,670
| -96% | -$22.4M |
|
1896
Universal Corp
UVV
$1.14B
| $857K | ﹤0.01% |
14,098
+954
| +7% | +$53.5K |
|
|
BRKL
1897
DELISTED
Brookline Bancorp
BRKL
| $856K | ﹤0.01% |
55,666
+100
| +0.2% | +$1.49K |
|
|
BBBY
1898
DELISTED
Bed Bath & Beyond Inc
BBBY
| $856K | ﹤0.01% |
73,627
+300
| +0.4% | +$4.45K |
|
1899
Fulton Financial
FULT
$4.69B
| $853K | ﹤0.01% |
52,104
+392
| +0.8% | +$6.45K |
|
1900
United Fire Group
UFCS
$1.38B
| $853K | ﹤0.01% |
17,593
+49
| +0.3% | +$2.24K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.